Effects of Chronic Fluoxetine in Animal Models of Anxiety and Depression
The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Abstract
The onset of the therapeutic response to antidepressant treatment exhibits a characteristic delay. Animal models sensitive to chronic, but not acute, antidepressant treatment are greatly needed for studying antidepressant mechanisms. We initially assessed four inbred mouse strains for their behavioral response to chronic treatment with the selective-serotonin reuptake inhibitor fluoxetine (0, 5, 10 mg/kg/day in drinking water), which is used for the treatment of mood and anxiety disorders. Only the highly anxious BALB/c strain exhibited sensitivity to fluoxetine in the forced swim test. Additionally, fluoxetine reduced locomotion in C57BL/6 and 129SvEv, but not BALB/c and DBA/2, strains. We then evaluated the effects of subchronic (approximately 4 days) and chronic (approximately 24 days) fluoxetine treatment (0, 10, 18, 25 mg/kg/day) on measures of anxiety and depression in BALB/c mice. Anxiety measures were obtained using the open field and novelty-induced hypophagia tests. Antidepressant effects were evaluated using the forced swim test. We found 18 mg/kg/day of chronic fluoxetine to be active in all three paradigms; subchronic treatment had no effect. Anxiety-related measures were reduced by 18 mg/kg/day. In the forced swim test, 10 and 18 mg/kg/day increased swimming and reduced immobility. Here we present several novel effects of chronic, but not subchronic, antidepressant treatment.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This dosage of 18 mg/kg/day have been shown to be in the upper range of the therapeutic dose of fluoxetine administered to humans.16”
From Synaptic Vesicle 2A (SV2A) Positron Emission Tomography (PET) Imaging as a Marker of Therapeutic Response in a Mouse Model of Depression (2025) · cites this paper as [16]
In the citing paper
“Hyponeophagia (novelty-suppressed feeding) has also been used to assess anxiety-like behavior in rodents; in a novel environment, hungry mice exhibit an increased latency to feed that is sensitive to benzodiazepines and SSRIs47,48.”
From Resolving the neural circuits of anxiety (2015) · cites this paper as [47]
In the citing paper
“The NIH paradigm is a sensitive measure for potential anxiolytic drugs and anxiogenic effects of withdrawal on both acute and extended drug administration paradigms (Dulawa et al., 2004;Dulawa and Hen, 2005).”
From Activation of α4β2*/α6β2* nicotinic receptors alleviates anxiety during nicotine withdrawal without upregulating nicotinic receptors (2014) · cites this paper as Dulawa et al., 2004
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. (2013) · Encyclopedia of Social Work · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,519
Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants
Santarelli, L., Saxe, M., Gross, C., Surget, A., Battaglia, F., Dulawa, S., Weisstaub, N., Lee, J., Duman, R., Arancio, O., et al. (2003) · Science · doi:10.1126/science.1083328 · Cited by 4,321 · cited 1×
“We have previously shown that steady state for both fluoxetine and norfluoxetine is achieved by 5 days of receiving fluoxetine in the drinking water (10 mgskgsday), as serum levels after 5 or 90 days of treatment are equivalent (”
BackgroundSelf-citationBehavioral despair in mice: a primary screening test for antidepressants.
Porsolt, R. D., Bertin, A., & Jalfre, M. (1977) · PubMed · Cited by 4,013
The open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: a review
Prut, L., & Belzung, C. (2003) · European Journal of Pharmacology · doi:10.1016/s0014-2999(03)01272-x · Cited by 3,175
Willner, P. (1997) · Psychopharmacology · doi:10.1007/s002130050456 · Cited by 1,832 · cited 1×
“The intake of palatable fluids, including sucrose and saccharin solutions, has been used as a measure of reward sensitivity (”
MethodAssessing antidepressant activity in rodents: recent developments and future needs
Cryan, J. F., Markou, A., & Lucki, I. (2002) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(02)02017-5 · Cited by 1,551
Psychopharmacology: The Fourth Generation of Progress
Green, A. I. (1996) · Psychiatric Services · doi:10.1176/ps.47.3.312 · Cited by 1,145
Neuropsychopharmacology: The Fifth Generation of Progress
SAGDUYU, K. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.7.1251-a · Cited by 1,019
Pharmacokinetics of selective serotonin reuptake inhibitors
Hiemke, C., & Härtter, S. (2000) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(99)00048-0 · Cited by 883
Antidepressants and neuroplasticity
D'Sa, C., & Duman, R. S. (2002) · Bipolar Disorders · doi:10.1034/j.1399-5618.2002.01203.x · Cited by 513 · cited 1×
“These long-term effects are thought to involve increases in neural plasticity and growth-related events (”
Background
Research works printed but not linked: 2
- Hirschfeld R, Weisssman M (2002). Risk factors for major depression and bipolar disorder. In: Davis K, Charney D, Coyle J, Nemeroff C (eds). Neuropsychopharmacology: The Fifth Generation of Progress. Lippincott Williams & Wilkins: Philadelphia. pp 1018–1025.
- Merikangas K, Pine D (2002). Genetic and other vulnerability factors for anxiety and stress disorders. In: Davis K, Charney D, Coyle J, Nemeroff C (eds). Neuropsychopharmacology: The Fifth Generation of Progress. Lippincott Williams & Wilkins: Philadelphia. pp 868–882.
Cited by
Items 401–500 of 693
Sun, X., Zhou, Z., Liu, T., Zhao, M., Zhao, S., Xiao, T., Jolkkonen, J., & Zhao, C. (2015) · Journal of Molecular Neuroscience · doi:10.1007/s12031-015-0662-y · Cited by 20
“The experiments were performed on aged (18–20 months) male Sprague Dawley rats (600–800 g) divided into four groups at the beginning of the experiment: sham-operated rats (n = 8, SHAM), sham-operated rats treated with fluoxetine (n = 8, SHAM + FLUO), rats subjected to cerebral ischemia (n = 8,…”
MethodWang, Q., Long, Y., Hang, A., Zan, G., Shu, X. H., Wang, Y., & Liu, J. (2016) · Psychopharmacology · doi:10.1007/s00213-016-4292-z · Cited by 20
“Locomotor activity was measured as described previously (Dulawa et al. 2004) with slight modification.”
Weaver, S. R., Fricke, H. P., Xie, C., Lipinski, R. J., Vezina, C. M., Charles, J. F., & Hernandez, L. L. (2018) · Endocrinology · doi:10.1210/en.2018-00279 · Cited by 20
McMurray, K. M. J., Strawn, J. R., & Sah, R. (2018) · Neuroscience · doi:10.1016/j.neuroscience.2018.10.042 · Cited by 19
Mncube, K., Möller, M., & Harvey, B. H. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.688150 · Cited by 20
“Moreover, and congruent with literature (79, 80), these anxiety-like behaviours were effectively reversed by FLX (d = 1.”
BackgroundEffect of fluoxetine on induced tooth movement in rats
Frigotto, G. C. F., de Araújo, C. M., Filho, O. G., Tanaka, O. M., Johann, A. C. B. R., & Camargo, E. S. (2015) · American Journal of Orthodontics and Dentofacial Orthopedics · doi:10.1016/j.ajodo.2015.04.031 · Cited by 19
Phenotypic instability between the near isogenic substrains BALB/cJ and BALB/cByJ
Sittig, L. J., Jeong, C., Tixier, E. N., Davis, J. R., Barrios-Camacho, C. M., & Palmer, A. A. (2014) · Mammalian Genome · doi:10.1007/s00335-014-9531-1 · Cited by 19
“…exhibit aggressive, anxious, and stress-reactive behaviors and are sensitive to certain effects of chronic antidepressant treatment (Potter 1985; Dulawa et al. 2004; Crowley et al. 2005, 2006; Englander et al. 2005; Sankoorikal et al. 2006; Holick et al. 2008; Norcross et al. 2008; Poulter et…”
BackgroundSprague-Dawley and Fischer Female Rats Differ in Acute Effects of Fluoxetine on Sexual Behavior
Miryala, C. S. J., Hiegel, C., & Uphouse, L. L. (2012) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2012.02981.x · Cited by 19
Robinson, S. A., Brookshire, B. R., & Lucki, I. (2016) · Neurobiology of Stress · doi:10.1016/j.ynstr.2015.12.005 · Cited by 23
“…of feeding in a novel environment, is a behavioral measure of stress that may be sensitive to the anxiolytic effects of chronic, but not acute, antidepressant treatment with SSRIs (Bechtholt et al., 2007; Bodnoff et al., 1988; Bodnoff et al., 1989; Dulawa and Hen, 2005; Dulawa et al., 2004).”
BackgroundInfluentialFailure to detect the action of antidepressants in the forced swim test in Swiss mice
Suman, P. R., Zerbinatti, N., Theindl, L. C., Domingues, K., & de Oliveira, C. L. (2017) · Acta Neuropsychiatrica · doi:10.1017/neu.2017.33 · Cited by 19
The New Statistics for Neuroscience Majors: Thinking in Effect SizesPreprint
Calin-Jageman, R. J. (2018) · PsyArXiv (OSF Preprints) · doi:10.31234/osf.io/zvm9a · Cited by 19
“In the Dulawa et al. (2004) experiment, the overlap is 69% [42, 100].”
BackgroundMethodInfluentialCervin, M., Storch, E. A., Piacentini, J., Birmaher, B., Compton, S. N., Albano, A. M., Gosch, E., Walkup, J. T., & Kendall, P. C. (2020) · Journal of Child Psychology and Psychiatry · doi:10.1111/jcpp.13124 · Cited by 18
Ortuño, M. J., Schneeberger, M., Ilanges, A., Marchildon, F., Pellegrino, K., Friedman, J. M., & Ducy, P. (2021) · Journal of Clinical Investigation · doi:10.1172/jci151976 · Cited by 19
“Notably, our results are consistent with previous observations reported in studies in which Flx was delivered orally, although those studies used different doses and were not designed to evaluate this drug’s effect on feeding (39, 40).”
ResultStanisavljević, A., Perić, I., Gass, P., Inta, D., Lang, U. E., Borgwardt, S., & Filipović, D. (2020) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2020.07.021 · Cited by 18
Carratalá‐Ros, C., López‐Cruz, L., Martínez-Verdú, A., Olivares-García, R., Salamone, J. D., & Correa, M. (2021) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2021.700182 · Cited by 19
“Previous studies have shown the same pattern; fluoxetine increases active behaviors (swimming and climbing) and decreases passive ones (immobility) in different strains of mice after acute or chronic administration of this SERT blocker (Lucki et al., 2001; Dulawa et al., 2004; Sanmukhani et al., 2011; Costa et al., 20…”
BackgroundStan, T. L., Sousa, V. C., Zhang, X., Ono, M., & Svenningsson, P. (2015) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2015.07.007 · Cited by 18
“The dose of fluoxetine, 20 mg/kg, was chosen based on the original report by Dulawa et al. (2004) demonstrating a significant latency to feed in the novelty-induced hypophagia test at this dose.”
BackgroundMethodResultInfluentialComparison of the predictive validity of the mirror chamber and elevated plus maze tests in mice
Paterson, N. E., Iwunze, M., Davis, S. F., Malekiani, S. A., & Hanania, T. (2010) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2010.02.005 · Cited by 19
Eitan, R., Landshut, G., Lifschytz, T., Einstein, O., Ben‐Hur, T., & Lerer, B. (2009) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145709990769 · Cited by 20
Guirado, R., LaTerra, D., Bourguignon, M., Carceller, H., Umemori, J., Sipilä, P., Nácher, J., & Ċastrén, E. (2016) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2016.00022 · Cited by 19
“This protocol of chronic Fluoxetine administration to adult mice was reported to result in clinical relevant plasma levels of the drug (Dulawa et al., 2004).”
BackgroundHansen, F., de Oliveira, D. L., Amaral, F. U. Í., Guedes, F. S., Schneider, T. J., Tumelero, A. C., Hansel, G., Schmidt, K. H., Giacomini, A. C. V. V., & Torres, F. V. (2011) · Neuroscience Letters · doi:10.1016/j.neulet.2011.05.032 · Cited by 18
Otsuka, S., Ohkido, T., Itakura, M., Watanabe, S., Yamamori, S., Iida, Y., Saito, M., Miyaoka, H., & Takahashi, M. (2016) · Epilepsy Research · doi:10.1016/j.eplepsyres.2016.04.007 · Cited by 17
Rafi, H., Rafiq, H., & Farhan, M. (2021) · Beni-Suef University Journal of Basic and Applied Sciences · doi:10.1186/s43088-021-00118-7 · Cited by 24
“BALB/c mice demonstrated that chronic FLX treatment increased time spent in the central region of the open field box specifically in the first few minutes of test cutoff time [33].”
BackgroundBen‐Azu, B., Adebayo, O. G., Adebesin, A., Oparaji, K. C., Ojiakor, V. O., Pender, G. C., Odeghe, B. O., Omeiza, N. A., Abdulrahim, H. A., Ezieshi, V., et al. (2024) · Journal of Affective Disorders Reports · doi:10.1016/j.jadr.2024.100814 · Cited by 22
Can, A., Piantadosi, S. C., & Gould, T. D. (2013) · Psychopharmacology · doi:10.1007/s00213-013-3045-5 · Cited by 17
“…antidepressant treatments (Bai et al. 2001; Can et al. 2011; Cervo et al. 2005; Crowley et al. 2005; David et al. 2003; Dubocovich et al. 1990; Dulawa et al. 2004; Liu and Gershenfeld 2001; Lucki et al. 2001; Nomura et al. 1991; Porsolt et al. 1978; Ripoll et al. 2003; van der Heyden et al.…”
Poggini, S., Bon, G. M., Golia, M. T., Albanese, N. C., Viglione, A., Poleggi, A., Limatola, C., Maggi, L., & Branchi, I. (2021) · Behavioural Brain Research · doi:10.1016/j.bbr.2021.113256 · Cited by 21
Perić, I., Stanisavljević, A., Gass, P., & Filipović, D. (2021) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2021.05.021 · Cited by 18
Hernández, A., & Fernández‐Guasti, A. (2018) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2018.05.017 · Cited by 17
“, 2015; Salchner and Singewald, 2006, 2002), while after chronic or subchronic administrations it produces anxiolytic- and antidepressive-like effects (Dulawa et al., 2004; Martínez-Mota and Fernández-Guasti, 2004; EstradaCamarena et al., 2011; Olivares-Nazario et al., 2015).”
Zaidan, H., Ramaswami, G., Barak, M., Li, J. B., & Gaisler-Salomon, I. (2018) · Environmental Epigenetics · doi:10.1093/eep/dvy021 · Cited by 18
Aggression and anxiety in adolescent AAS-treated hamsters: A role for 5HT3 receptors
Morrison, T. R., Ricci, L. A., & Melloni, R. H. (2015) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2015.05.001 · Cited by 17
“Indeed, although the enhancement of tonic 5HT has predominantly been aligned with inhibition of aggression and anxiety (Deleon et al., 2002; Dulawa et al., 2004; Ferris and Delville, 1994; Perreault et al., 2003; Rogóz and Skuza, 2011), only few studies have targeted the 5HT3 receptor to show increased 5HT signaling e…”
BackgroundExploring Female Mice Interstrain Differences Relevant for Models of Depression
Calçada, D. D. S., Roque, S., Branco, C., Monteiro, S., Cerqueira-Rodrigues, B., Sousa, N., Palha, J. A., & Correia‐Neves, M. (2015) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2015.00335 · Cited by 17
“For example, four inbred mouse strains showed different locomotion and depressive-like behavior outcomes upon the same fluoxetine’s treatment (Dulawa et al., 2004); seven inbred mouse strains were shown to respond differently, in terms of behavior and various biometric and molecular parameters, to…”
BackgroundLin, S., Chen, Z., Wu, Z., Fei, F., Xu, Z., Tong, Y., Sun, W., & Wang, P. (2023) · Neurochemical Research · doi:10.1007/s11064-023-04051-2 · Cited by 17
“L (20 mg/kg) group, (c) CRO-M (40 mg/kg) group, (d) CRO-H (80 mg/kg) group [39–41], (e) fluoxetine hydrochloride (positive control group, 20 mg/kg, Patheon France) group [42–44].”
Germán-Ponciano, L. J., Rosas-Sánchez, G. U., Ortiz-Guerra, S. I., Soria-Fregozo, C., & Rodríguez‐Landa, J. F. (2021) · Revista Brasileira de Farmacognosia · doi:10.1007/s43450-021-00164-3 · Cited by 16
Funayama, Y., Li, H., Ishimori, E., Kawatake-Kuno, A., Inaba, H., Yamagata, H., Seki, T., Nakagawa, S., Watanabe, Y., Murai, T., et al. (2022) · Biological Psychiatry Global Open Science · doi:10.1016/j.bpsgos.2021.12.009 · Cited by 19
“For continuous treatment with imipramine hydrochloride (IMI), maprotiline hydrochloride (MPR), sertraline hydrochloride (SRT), and duloxetine hydrochloride (DLX), the drugs were dissolved in tap water to a concentration of 160 mg/L (17,20,21) and administered for 3 weeks (long-term) or 5 days (short-term).”
MethodPsychological stress impairs ischemia-induced neovascularization: Protective effect of fluoxetine
Maingrette, F., Dussault, S., Dhahri, W., Desjarlais, M., Mathieu, R., Turgeon, J., Haddad, P., Groleau, J., Pérez, G., & Rivard, A. (2015) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2015.06.010 · Cited by 17
Alter, D., Beverley, J. A., Patel, R., Bolaños‐Guzmán, C. A., & Steiner, H. (2017) · Journal of Psychopharmacology · doi:10.1177/0269881117715598 · Cited by 16
“The FLX dose is in the clinically relevant range (Dulawa et al., 2004; Rantamäki et al., 2007).”
BackgroundMcCloskey, M. C., Young, T. J., & Anderson, S. M. (2017) · BIOS · doi:10.1893/bios-d-15-00013.1 · Cited by 16
“…administered drugs known to reduce anxiety in humans show reduced latency to lick a sweetened 0.2% saccharin solution in a novel environment in the NIH task and increased time spent in the center in the open field test (Dulawa, 2010; Dulawa et al., 2004; Gould et al., 2010; Turner et al., 2010).”
BackgroundInfluentialCunningham, A. M., Santos, T. L., Gutzeit, V. A., Hamilton, H. C., Hen, R., & Donaldson, Z. R. (2019) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.8b00638 · Cited by 16
Self-citationCYP 450 enzymes influence (R,S)-ketamine brain delivery and its antidepressant activity
Nguyen, T. M. L., McGowan, J. C., & Gardier, A. M. (2021) · Neuropharmacology · doi:10.1016/j.neuropharm.2021.108936 · Cited by 17
Xiong, G.-J., Yang, Y., Cao, J., Mao, R., & Xu, L. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2014.12.026 · Cited by 17
“Fluoxetine, a selective serotonin reuptake inhibitor (SSRI), shows great anxiolytic and antidepressant efficacy in clinical and animal studies (Birmaher et al., 2003; Dulawa et al., 2004; Hurst and Lamb, 2000).”
BackgroundZhu, B., Sun, Y., Sun, Z., Yang, G., Zhou, C., & Zhu, R.-S. (2012) · CNS Neuroscience & Therapeutics · doi:10.1111/j.1755-5949.2012.00315.x · Cited by 15
“It is reported that serum Flx levels in adult BALB/c mice receiving 10–18 mg/kg/day chronic Flx have been shown to be comparable to those in human patients receiving 20–80 mg Flx (Prozac) per day [36].”
MethodTsafack, E. G., Mbiantcha, M., Ateufack, G., Nguemnang, S. F. D., Nana, W. Y., Atsamo, A. D., Marthe, V. M. M., Adjouzem, C. F., & Besong, E. B. (2021) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2021/6637584 · Cited by 16
“To assess depression and antidepressant compounds, these tests are still the most widely standard [61].”
BackgroundIacono, L. L., Ielpo, D., Parisi, C., Napoli, G., Accoto, A., Segni, M. D., Babicola, L., D’Addario, S. L., Guzzo, S. M., Pascucci, T., et al. (2021) · Neuropharmacology · doi:10.1016/j.neuropharm.2021.108559 · Cited by 15
Differential Molecular Responses of Zebrafish Larvae to Fluoxetine and Norfluoxetine
Rodrigues, P., Cunha, V. F. P. M., Ferreira, M., Reis-Henriques, M. A., Oliva-Teles, L., Guimarães, L., & Carvalho, A. P. (2022) · Water · doi:10.3390/w14030417 · Cited by 15
“depression, anxiety and food and panic disturbances [4].”
BackgroundKim, S., Kim, S., Khalid, A., Jeong, Y., Jeong, B., Lee, S., Jung, K., Chu, K., Lee, S. K., & Jeon, D. (2016) · PLoS ONE · doi:10.1371/journal.pone.0145374 · Cited by 16
“The dose and duration were chosen based on the procedures of previous studies [35,39,40].”
BackgroundMethodFlores‐Ramirez, F. J., Themann, A., Sierra-Fonseca, J. A., Garcia-Carachure, I., Castillo, S. A., Rodriguez, M., Lira, O., Preciado-Piña, J., Warren, B. L., Robison, A. J., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-87378-6 · Cited by 16
Influence of Panax ginseng on the offspring of adult rats exposed to prenatal stress
Kim, Y. O., LEE, H.-Y., Won, H., Nah, S., LEE, H.-Y., KIM, H.-K., Kwon, J., & KIM, H.-J. (2014) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2014.2003 · Cited by 15
“Scoring included central boxes entered, line crossings, runs, rears, grooming, cage sniffs and immobile behavior, as previously described (29,30).”
InfluentialConnor, D. A., & Gould, T. J. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.07.033 · Cited by 15
Delta Opioid Receptor-Mediated Antidepressant-Like Effects of Diprenorphine in Mice
Olson, K. M., Hillhouse, T. M., Burgess, G. E., West, J. L., Hallahan, J. E., Dripps, I. J., Ladetto, A. G., Rice, K. C., Jutkiewicz, E. M., & Traynor, J. R. (2022) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.122.001182 · Cited by 14
“Diprenorphine is effective following a single dose in the NIH assay which requires chronic dosing with traditional antidepressants and can therefore detect rapidly acting antidepressants (Dulawa et al., 2004; Saavedra et al., 2020), including ketamine (Louderback et al., 2013).”
BackgroundFilipović, D., Costina, V., Findeisen, P., & Inta, D. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232315351 · Cited by 16
“, 2017); these levels corresponded to those repo ted in the serum of patients after treatment with doses of 20–80 mg/day of Prozac (100–700 g/mL) [52].”
BackgroundFilipović, D., Novak, B., Xiao, J., Yan, Y., Bernardi, R. E., & Turck, C. W. (2023) · Journal of Proteomics · doi:10.1016/j.jprot.2023.104925 · Cited by 14
Differential susceptibility of BALB/c, C57BL/6N, and CF1 mice to photoperiod changes
Pilz, L. K., Quiles, C. L., Dallegrave, E., Levandovski, R. M., Hidalgo, M. P. L., & Elisabetsky, E. (2015) · Brazilian Journal of Psychiatry · doi:10.1590/1516-4446-2014-1454 · Cited by 14
Effect of Valeriana fauriei extract on the offspring of adult rats exposed to prenatal stress
Lee, H., Won, H., Im, J., Kim, Y. O., Lee, S., Cho, I., Kim, H.-K., Kwon, J., & Kim, H.-J. (2016) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2016.2589 · Cited by 14
“The experimenter exited the room, and the behavior of the subject was recorded, as previously described (37-39).”
Serotonin 5-HT3 receptor antagonism potentiates the antidepressant activity of citalopram
Perez-Palomar, B., Mollinedo-Gajate, I., Berrocoso, E., Meana, J. J., & Ortega, J. E. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2018.02.020 · Cited by 14
“Swimming behaviour relies on the serotonergic system and climbing behaviour on the noradrenergic system in mice (Dulawa et al., 2004; Holick et al., 2008).”
Assessment of the rapid and sustained antidepressant-like effects of dextromethorphan in mice
Saavedra, J. S., Garrett, P. I., Honeycutt, S. C., Peterson, A. M., White, J., & Hillhouse, T. M. (2020) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2020.173003 · Cited by 15
Gaszner, T., Farkas, J. I., Kun, D., Ujvari, B., Berta, G., CSERNUS, V. J., Füredi, N., Kovács, L. Á., Hashimoto, H., Reglődi, D., et al. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.995900 · Cited by 15
“This is in line with earlier results suggesting a slight anxiogenic effect of fluoxetine administration in non-stressed mice (121).”
ResultBehavioral Pharmacology: Potential Antidepressant and Anxiolytic Properties
Wesołowska, A., & Jastrzębska‐Więsek, M. (2011) · International review of neurobiology · doi:10.1016/b978-0-12-385902-0.00003-6 · Cited by 14
“…observed in the defensive burying test were similar to the effects produced by established anxiolytic drugs (Bodnoff et al., 1989; Treit et al., 1981) as well as by chronic treatment with antidepressants (Bechtholt et al., 2008; Bodnoff et al., 1988; Bondi et al., 2007; Dulawa et al., 2004).”
ResultMinding Nature: A Defense of a Sentiocentric Approach to Environmental Ethics
MacClellan, J. (2012) · Cited by 14
Developing Zebrafish Depression-Related Models
Pittman, J. T., & Piato, Â. (2017) · Springer eBooks · doi:10.1007/978-3-319-33774-6_2 · Cited by 15
Duarte, B., Feijão, E., de Carvalho, R. C., Duarte, I. A., Marques, A., Maia, M., Hertzog, J., Matos, A. R., Cabrita, M. T., Caçador, I., et al. (2022) · Biology · doi:10.3390/biology11121770 · Cited by 14
Chourbaji, S., Pfeiffer, N., Dormann, C., Brandwein, C., Fradley, R. L., Sheardown, M., & Gass, P. (2010) · Behavioural Brain Research · doi:10.1016/j.bbr.2010.03.019 · Cited by 14
Yin, S.-H., Wang, C., Cheng, T., Chang, C., Lin, K., Kan, W., Wang, H., Kao, W. M.-W., Kuo, Y.-L., Chen, J., et al. (2012) · Chinese Medicine · doi:10.1186/1749-8546-7-24 · Cited by 14
“It was reported that fluoxetine reduced locomotion in the C57BL/6 J and 129SvEv mouse strains, but not in the BALB/c and DBA/2 mouse strains [24].”
BackgroundInfluentialLee, S., Remark, L. H., Buchalter, D. B., Josephson, A. M., Wong, M. Z., Litwa, H. P., Ihejirika-Lomedico, R. C., Leclerc, K., Markus, D. H., Yim, N. L., et al. (2019) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.3950 · Cited by 13
Kyi‐Tha‐Thu, C., Fujitani, Y., Hirano, S., & Win‐Shwe, T. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms24010586 · Cited by 13
“Novelty-induced hypophagia (NIH) is a validated test for anxiety-like behavior induced by a new environment [27,28].”
BackgroundHuang, J., Xie, X., Lyu, N., Fu, B., Zhao, Q., Zhang, L., & Wang, G. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1115008 · Cited by 14
Lamoureux, L., Beverley, J. A., Marinelli, M., & Steiner, H. (2023) · Addiction Neuroscience · doi:10.1016/j.addicn.2023.100131 · Cited by 12
“This FLX dose is in the clinically relevant range [34,35], while the MP dose is at the upper limit or above of doses used clinically and is thus likely more relevant for MP abuse (see [11]).”
BackgroundAyrancı, G., Befort, K., Lalanne, L., Kieffer, B. L., & Lutz, P.-É. (2014) · Psychopharmacology · doi:10.1007/s00213-014-3826-5 · Cited by 15
Nicolas, C., Russell, T. I., Shaham, Y., & Ikemoto, S. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.824741 · Cited by 14
Narvik, J., Vanaveski, T., Innos, J., Philips, M., Ottas, A., Haring, L., Zilmer, M., & Vasar, E. (2018) · Scientific Reports · doi:10.1038/s41598-018-21752-9 · Cited by 14
Dulawa, S. C. (2007) · Neuromethods · doi:10.1007/978-1-60761-303-9_13 · Cited by 14
Self-citationLegrand, M., Galineau, L., Novell, A., Planchez, B., Brizard, B., Leman, S., Tauber, C., Escoffre, J., Lefèvre, A., Gosset, P., et al. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/813006 · Cited by 14
Benham, R. S., Hewage, N. B., Suckow, R. F., Engin, E., & Rudolph, U. (2017) · Behavioural Brain Research · doi:10.1016/j.bbr.2017.05.063 · Cited by 11
“Importantly, the combined FLX and norfluoxetine plasma levels detected following chronic FLX 4 mg/kg and 8 mg/kg treatment were within the therapeutic range of 100–700 ng/mL[25].”
InfluentialModulation of serotonin transporter expression by escitalopram under inflammation
Mena, S., Cruikshank, A., Best, J. A., Nijhout, H. F., Reed, M. C., & Hashemi, P. (2024) · Communications Biology · doi:10.1038/s42003-024-06240-3 · Cited by 13
Millard, S. J., Lum, J. S., Fernandez, F., Weston–Green, K., & Newell, K. A. (2020) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2020.110174 · Cited by 12
Sadeghi, M. A., Hemmati, S., Yousefi‐Manesh, H., Fekrvand, S., Foroutani, L., Nassireslami, E., Zoshk, M. Y., Hosseini, Y., Dehpour, A. R., & Chamanara, M. (2022) · Behavioural Brain Research · doi:10.1016/j.bbr.2022.114128 · Cited by 11
Chronic fluoxetine dissociates contextual from auditory fear memory
Sanders, J., & Mayford, M. R. (2016) · Neuroscience Letters · doi:10.1016/j.neulet.2016.08.057 · Cited by 12
“Chronic fluoxetine treatment has been defined as between 24–30 days according to prior studies [16, 21, 22].”
MethodResultRayan, N. A., Aow, J., Lim, M. G. L., Arcego, D. M., Ryan, R., Nourbakhsh, N., de Lima, R. M. S., Craig, K., Zhang, T., Goh, Y. T., et al. (2024) · Molecular Psychiatry · doi:10.1038/s41380-024-02619-0 · Cited by 13
Sarkar, I., Snippe-Strauss, M., Zamir, A. T., Benhos, A., & Richter‐Levin, G. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.1071482 · Cited by 11
“Despite that, the accepted approach of measuring efficacy of pharmacological treatments in animal models of psychiatric disorders refers to averaged group results (Katz and Hersh, 1981; Bodnoff et al., 1989; Rudolph and Feiger, 1999; Dulawa et al., 2004).”
BackgroundLevone, B. R., Moloney, G. M., Cryan, J. F., & O’Leary, O. F. (2021) · Neurobiology of Stress · doi:10.1016/j.ynstr.2021.100331 · Cited by 10
Adongo, D. W., Mante, P. K., Kukuia, K. K. E., Benneh, C. K., Biney, R. P., Boakye‐Gyasi, E., Amekyeh, H., Harley, B. K., Tandoh, A., Okyere, P. D., et al. (2023) · PLoS ONE · doi:10.1371/journal.pone.0278231 · Cited by 10
Fluoxetine triggers selective apoptosis in inflammation‐induced proliferating (Ki‐67high) thymocytes
Ghosh, S., Choudhury, S., Mukherjee, S., Gupta, P., Chowdhury, O., Baral, R., & Chattopadhyay, S. (2018) · Immunology and Cell Biology · doi:10.1111/imcb.12227 · Cited by 10
Zebrafish models of impulsivity and impulse control disorders
de Abreu, M. S., Giacomini, A. C. V. V., Genário, R., Fontana, B. D., Parker, M. O., Marcon, L., Scolari, N., Bueno, B. W., Demin, K. A., Galstyan, D. S., et al. (2020) · European Journal of Neuroscience · doi:10.1111/ejn.14893 · Cited by 10
Payet, J. M., Wilson, K.-E., Russo, A. M., Angiolino, A., Kavanagh-Ryan, W., Kent, S., Lowry, C. A., & Hale, M. W. (2021) · Behavioural Brain Research · doi:10.1016/j.bbr.2021.113268 · Cited by 10
Filipović, D., Inderhees, J., Korda, A. I., Tadic, P. R., Schwaninger, M., Inta, D., & Borgwardt, S. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241310957 · Cited by 9
“Flx serum concentrations were similar to those reported in the serum of patients effectively treated with Prozac [35,72].”
ResultAlyoshina, N. M., Tkachenko, M. D., Nikishina, Y. O., & Никишин, Д. А. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241411247 · Cited by 9
“Despite SSRIs’ ability for rapid inhibition of SERT activity [34], efficacy of treatment can be seen only after chronic administration, due to neuroadaptive changes.”
BackgroundInfluentialPayet, J. M., Stevens, L., Russo, A. M., Jaehne, E. J., van den Buuse, M., Kent, S., Lowry, C. A., Baratta, M. V., & Hale, M. W. (2023) · Neuroscience · doi:10.1016/j.neuroscience.2023.10.003 · Cited by 9
Kong, C. H., Lee, J. W., Jeon, M., Kang, W. C., Kim, M. S., Park, K., Bae, H. J., Park, S. J., Jung, S. Y., Kim, S., et al. (2024) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2024.110990 · Cited by 9
Vierci, G., Oliveira, C. S., Perera, L. R., Bornia, N., Leal, R. B., & Rossi, F. (2012) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2012.10.003 · Cited by 9
“This dose of fluoxetine was chosen because similar doses have been found to be efficacious on cellular, molecular or functional readouts in previous studies (Dulawa et al., 2004; Karpova et al., 2009; Rantamäki et al., 2007; Maya-Vetencourt et al., 2008; Chen et al., 2011).”
BackgroundNashed, M. G., Waye, S., Hasan, S. M. N., Nguyen, D., Wiseman, M., Zhang, J., Lau, H., Dinesh, O. C., Raymond, R., Greig, I. R., et al. (2022) · Psychopharmacology · doi:10.1007/s00213-021-06045-w · Cited by 10
“The NIH is a modification of the NSFT that replaces standard chow with a sweetened palatable food and eliminates the need for food deprivation while similarly assessing anxietylike behaviors (Dulawa et al. 2004).”
MethodFricke, H. P., & Hernandez, L. L. (2023) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1007/s10911-023-09535-z · Cited by 10
Zebrafish, a Potential Novel Research Tool for the Analysis and Modeling of Anxiety
Gerlai, R. T. (2011) · InTech eBooks · doi:10.5772/24100 · Cited by 10
“Interestingly, these behavioural changes were accompanied by reduced whole-body cortisol levels (Egan et al., 2009), responses that parallel those seen in rodents (Dulawa et al., 2004).”
Rainer, Q., Gardier, A. M., Hen, R., & David, D. J. P. (2009) · médecine/sciences · doi:10.1051/medsci/20092510795 · Cited by 9
Self-citationNarboux‐Nême, N., Aouci, R., Fontaine, A., Vion, A., Levi, G., & Belz, L. (2024) · Cells · doi:10.3390/cells13151262 · Cited by 10
“(b) For short-term acute treatments, Flx was dissolved in 0.9% NaCl and administered intraperitoneally (15 mg/kg/day [60]) to C57/BL6 mice.”
BackgroundMethodInfluentialMesripour, A., & Golchin, S. (2022) · Iranian Journal of Psychiatry · doi:10.18502/ijps.v17i2.8911 · Cited by 11
Mncube, K., & Harvey, B. H. (2022) · IBRO Neuroscience Reports · doi:10.1016/j.ibneur.2022.08.009 · Cited by 8
GABAA Receptor α1 Subunit (Gabra1) Knockout Mice: Review and New Results
Ye, G.-L., Baker, K. B., Mason, S. M., Zhang, W., Kirkpatrick, L., Lanthorn, T. H., & Savelieva, K. V. (2009) · Neuromethods · doi:10.1007/978-1-60761-474-6_4 · Cited by 10
Kudryashov, N. V., Калинина, Т. С., Shimshirt, A. A., Королев, А. О., Волкова, А. В., & Воронина, Т. А. (2017) · Behavioural Pharmacology · doi:10.1097/fbp.0000000000000359 · Cited by 8
Абдуллина, А. А., Васильева, Е. В., Kulikova, E. A., Naumenko, V. S., Plyusnina, A. V., Гудашева, Т. А., Kovalev, G. I., & Середенин, С. Б. (2022) · Journal of Psychopharmacology · doi:10.1177/02698811211069101 · Cited by 8
“, 2019), and literature data showing that serum fluoxetine levels for the 10 mg/kg/day dose correspond with the bottom of the range of plasma levels found in patients taking 20–80 mg/day Prozac (Dulawa et al., 2004).”
BackgroundScarante, F. F., Lopes, V. D., Fusse, E. J., Vicente, M. A., de Abreu, G. H. D., Nardini, V., Sorgi, C. A., Lirio, P. H. C., Guo, F., Lu, H., et al. (2026) · Neuropharmacology · doi:10.1016/j.neuropharm.2026.110894 · Cited by 8
Dendritic Spine Density is Increased in Arcadlin-deleted Mouse Hippocampus
Takeuchi, C., Ishikawa, M., Sawano, T., Shin, Y., Mizuta, N., Hasegawa, S., Tanaka, R., Tsuboi, Y., Nakatani, J., Sugiura, H., et al. (2020) · Neuroscience · doi:10.1016/j.neuroscience.2020.06.037 · Cited by 9
Manning, E. E., Wang, A. Y., Saikali, L. M., Winner, A. S., & Ahmari, S. E. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/694935 · Cited by 8
Metadata
- Authors
- Dulawa, S. C., Holick, K. A., Gundersen, B., & Hen, R.
- Affiliations
- Columbia University (US)
- Venue
- Neuropsychopharmacology
- Published
- 2004-04-07
- Volume
- 29
- Issue
- 7
- Pages
- 1321-1330
- ISSN
- 0893-133X (ISSN-L)
- 1740-634X
- OpenAlex
- W1987972424
- Cited by
- 671
- References
- 50
- Citations by year
- 2026: 16 · 2025: 21 · 2024: 27 · 2023: 28 · 2022: 32 · 2021: 32 · 2020: 31 · 2019: 51 · 2018: 31 · 2017: 42 · 2016: 34 · 2015: 42 · 2014: 41 · 2013: 44 · 2012: 28
- FWCI
- 9.00
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Neuropsychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Alliance for Research on Schizophrenia and Depression (MH068542-1)
- National Institutes of Health (5r01da009862-08, 5f32mh065791-02)
- National Institute of Mental Health (F32-MH65791-01A1, P50MH050733, P50-MH50733, R01 MH068542-1, R01MH068542)
- National Institute on Drug Abuse (R01 DA09862)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Keywords
- fluoxetine, chronic antidepressant treatment, anxiety, depression, selective serotonin reuptake inhibitors, inbred mouse strains, BALB/c mice, forced swim test, novelty-induced hypophagia, locomotor activity, antidepressant sensitivity
- MeSH terms
- Analysis of Variance, Animals, Anxiety, Behavior, Animal, Depression, Disease Models, Animal, Dose-Response Relationship, Drug, Drug Administration Schedule, Exploratory Behavior, Fluoxetine, Immobilization, Male, Mice, Inbred Strains, Motor Activity, Reaction Time, Species Specificity, Swimming, Time Factors, Selective Serotonin Reuptake Inhibitors, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.